Prof. Anne Demulder | Development Economics | Best Researcher Award

Anne Demulder, born on September 1, 1957, in Ixelles, Belgium, is a Belgian medical biologist specializing in hematology. She is a faculty member at Université libre de Bruxelles (ULB) and a consultant at LHUB-ULB. With a distinguished career in clinical biology, she has played a key role in hematology diagnostics, research, and laboratory management. Her contributions extend to academia, where she has trained pharmacists and biologists. Fluent in French, Dutch, English, and Spanish, she has also been involved in international medical cooperation.

Profile

• Orcid

Education

Dr. Demulder earned her MD from ULB in 1982, specializing in clinical biology. She completed postgraduate training in clinical chemistry, bacteriology, radioisotopes, and hematology at CHU Brugmann. In 1990-1991, she pursued postdoctoral research in hematology and endocrinology at the University of Texas Health Science Center, USA. She obtained a Master in Health Institution Management (2012-2013) and has been a clinical biology supervisor at ULB’s Faculty of Pharmacy.

Experience

Dr. Demulder has been a medical biologist at LHUB-ULB since 1992, serving as Chief of Hematology. She supervises hematological diagnostics, oversees laboratory quality assurance, and contributes to medical research. She previously worked as a postdoctoral fellow in the USA (1990-1992) and a resident in hematology at CHU Brugmann (1985-1989). She has played an active role in medical education, training pharmacists, biologists, and clinicians. She also contributed to international academic cooperation, particularly in Burkina Faso and Guinea.

Research Interests

Dr. Demulder’s research explores global hemostasis testing for hematologic disorders. She investigates hypercoagulability in sickle cell disease and leukemia patients undergoing asparaginase treatment. Her work also focuses on thrombin generation tests for personalized hemophilia therapy. Recently, she has studied coagulation abnormalities in acute and long COVID patients. Her research aims to enhance diagnostic accuracy and therapeutic approaches in hematology.

Awards & Recognitions

Dr. Demulder has received recognition for her contributions to hematology, clinical biology, and international cooperation. As an academic leader, she played a key role in laboratory standardization (ISO 15189) and was a member of the CHU Brugmann Medical Council. Her work in developing biomedical sciences in Africa through targeted university projects has been widely acknowledged. She has also been a pivotal figure in the integration of hematology services at LHUB-ULB.

Publications

• Exploring Hypercoagulability in Post-COVID Syndrome (PCS): An Attempt at Unraveling the Endothelial Dysfunction

  Journal of Clinical Medicine

  2025-01-25 | Journal article

  DOI: 10.3390/jcm14030789

  CONTRIBUTORS: Maxim Muys; Anne Demulder; Tatiana Besse-Hammer; Nathalie Ghorra; Laurence Rozen

• Assessment of Arteriovenous Fistula Maturation in Hemodialysis Patients with Persistently Positive Antiphospholipid Antibody: A Prospective Observational Cohort Study
  Life

  2025-01-24 | Journal article

  DOI: 10.3390/life15020168

  CONTRIBUTORS: Maxime Taghavi; Lucas Jacobs; Saleh Kaysi; Yves Dernier; Edouard Cubilier; Louis Chebli; Marc Laureys; Frédéric Collart; Anne Demulder; Marie-Hélène Antoine et al.

• Rivaroxaban presents a better pharmacokinetic profile than dabigatran in an obese non-diabetic stroke patient
  Journal of the Neurological Sciences

  2014-11 | Journal article

  DOI: 10.1016/j.jns.2014.09.008

  CONTRIBUTORS: Apostolos Safouris; Anne Demulder; Nikos Triantafyllou; Georgios Tsivgoulis